Related references
Note: Only part of the references are listed.Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C
K. Rutter et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study
Michael P. Curry et al.
GASTROENTEROLOGY (2015)
Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Sofosbuvir With Peginterferon-Ribavirin for 12 Weeks in Previously Treated Patients With Hepatitis C Genotype 2 or 3 and Cirrhosis
Eric Lawitz et al.
HEPATOLOGY (2015)
All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
David R. Nelson et al.
HEPATOLOGY (2015)
Safety profile of boceprevir and telaprevir in chronic hepatitis C: Real world experience from HCV-TARGET
Stuart C. Gordon et al.
JOURNAL OF HEPATOLOGY (2015)
Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy
Christoph Sarrazin et al.
JOURNAL OF VIROLOGICAL METHODS (2015)
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial
Eric Lawitz et al.
LANCET (2015)
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
Marc Bourliere et al.
LANCET INFECTIOUS DISEASES (2015)
Patient With Decompensated Hepatitis C Virus-Related Cirrhosis Delisted for Liver Transplantation After Successful Sofosbuvir-Based Treatment
Isaac Ruiz et al.
LIVER TRANSPLANTATION (2015)
Hepatitis C and its impact on renal transplantation
Jose M. Morales et al.
NATURE REVIEWS NEPHROLOGY (2015)
Clinical Evidence and Bioinformatics Characterization of Potential Hepatitis C Virus Resistance Pathways for Sofosbuvir
Eric F. Donaldson et al.
HEPATOLOGY (2015)
Global Distribution and Prevalence of Hepatitis C Virus Genotypes
Jane P. Messina et al.
HEPATOLOGY (2015)
High post-transplant virological response in hepatitis C virus infected patients treated with pretransplant protease inhibitor-based triple therapy
Elizabeth C. Verna et al.
LIVER INTERNATIONAL (2015)
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations
Clara T. M. M. de Kanter et al.
CLINICAL PHARMACOKINETICS (2014)
Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection
Gregory T. Everson et al.
GASTROENTEROLOGY (2014)
ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection
Pietro Andreone et al.
GASTROENTEROLOGY (2014)
Sticker Shock and the Price of New Therapies for Hepatitis C: Is It Worth It?
Nancy S. Reau et al.
HEPATOLOGY (2014)
Parallel 35: Hepatitis C: New Agents - Part 2
HEPATOLOGY (2014)
Generation of Functional Cholangiocyte-Like Cells From Human Pluripotent Stem Cells and HepaRG Cells
Noushin Dianat et al.
HEPATOLOGY (2014)
Life Expectancy in Patients With Chronic HCV Infection and Cirrhosis Compared With a General Population
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Global epidemiology and genotype distribution of the hepatitis C virus infection
Erin Gower et al.
JOURNAL OF HEPATOLOGY (2014)
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy
James R. Burton et al.
JOURNAL OF HEPATOLOGY (2014)
Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection
Johannes Vermehren et al.
JOURNAL OF HEPATOLOGY (2014)
Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience
Audrey Coilly et al.
JOURNAL OF HEPATOLOGY (2014)
An Interferon-free Antiviral Regimen for HCV after Liver Transplantation
Paul Y. Kwo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Retreatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Treatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin
Jordan J. Feld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Kris V. Kowdley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
ABT-450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV
Peter Ferenci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis
Jia-Jung Lee et al.
PLOS ONE (2014)
All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: A controlled study
Knut Boe Kielland et al.
JOURNAL OF HEPATOLOGY (2013)
PHARMACOKINETICS OF SIMEPREVIR (TMC435) IN VOLUNTEERS WITH MODERATE OR SEVERE HEPATIC IMPAIRMENT
S. Ouwerkerk-Mahadevan et al.
JOURNAL OF HEPATOLOGY (2013)
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)-NCT01514890
Christophe Hezode et al.
JOURNAL OF HEPATOLOGY (2013)
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
JOURNAL OF HEPATOLOGY (2013)
Multicenter Experience Using Telaprevir or Boceprevir With Peginterferon and Ribavirin to Treat Hepatitis C Genotype 1 After Liver Transplantation
Surakit Pungpapong et al.
LIVER TRANSPLANTATION (2013)
Global control of hepatitis C: where challenge meets opportunity
David L. Thomas
NATURE MEDICINE (2013)
The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007
Kathleen N. Ly et al.
ANNALS OF INTERNAL MEDICINE (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Safety and efficacy of treatment for chronic hepatitis C with a focus on pegylated interferons: the backbone of therapy today and in the future
Peter Ferenci
EXPERT OPINION ON DRUG SAFETY (2011)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
Edward J. Gane et al.
LANCET (2010)
Telaprevir for Previously Treated Chronic HCV Infection.
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
Marina Berenguer
JOURNAL OF HEPATOLOGY (2008)
Share Paper
